UncategorizedLilly wins FDA approval for new drug to slow Alzheimer’s fwadmin / July 3, 2024 The new Alzheimer’s drug will cost $32,000 for the first year of treatment.
UncategorizedJoe Biden and the tragedy of liberal denialism fwadmin / July 3, 2024 The left ignores problems on its own side, and recent history has turned on that failure
UncategorizedHow a London fund with a thorny history in Russia won global influence fwadmin / July 3, 2024 Gemcorp’s past activities in Africa appear aligned with the Kremlin’s strategic priorities. Now it has senior Conservatives on the payroll
UncategorizedMarket forces are not enough to halt climate change fwadmin / July 3, 2024 Investor returns imply that the welfare of future human beings is close to irrelevant
UncategorizedJapan’s first new banknotes in 20 years use holograms to defeat counterfeits fwadmin / July 3, 2024
UncategorizedAviat Networks Acquires 4RF, a Leading Provider of Industrial Wireless Access Solutions for Critical Infrastructure fwadmin / July 3, 2024
UncategorizedApproval of Eli Lilly’s New Alzheimer’s Drug Will Accelerate New Era of Treatment fwadmin / July 3, 2024 With the arrival of Lilly’s Kisunla, Alzheimer’s care could become more like treatment of cancer and rheumatoid arthritis and their regular infusions.
UncategorizedTesla Deliveries Slump but Not as Much as Feared fwadmin / July 3, 2024 Tesla’s vehicle sales slid for a second straight quarter but not as much as expected, lifting the company’s stock price and keeping Tesla the world’s largest seller of electric vehicles.